Abstract
Visceral leishmaniasis is a zoonotic disease in many countries and dogs are considered the main domestic reservoir of Leishmania parasites, and the presence of infected animals represents a potential risk for human disease. In this chapter, we review the state-of-the-art of canine visceral leishmaniasis (CanL) vaccines, discussing the properties and problems associated with the few currently licensed and discontinued vaccines and looking forward to the development of new, more effective vaccines. Reducing the incidence of CanL through vaccination will improve canine health and welfare and contribute to preventing human VL.
Author supplied keywords
Cite
CITATION STYLE
Coelho, E. A. F., & Christodoulides, M. (2023). Vaccines for Canine Leishmaniasis. In Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges: Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis (pp. 281–306). Springer International Publishing. https://doi.org/10.1007/978-3-031-24355-4_13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.